- Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Vazquez, E.R., Spigel, D.R., Raefsky, E., Bearden, J.D., Saez, R.A., Greco, F.A. Cancer (2008)